scispace - formally typeset
C

Charles J. Coté

Researcher at Harvard University

Publications -  228
Citations -  12354

Charles J. Coté is an academic researcher from Harvard University. The author has contributed to research in topics: Sedation & Pediatric anesthesia. The author has an hindex of 56, co-authored 227 publications receiving 11724 citations. Previous affiliations of Charles J. Coté include University of Duisburg-Essen & Northwestern University.

Papers
More filters
Journal ArticleDOI

Guidelines for Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures.

Charles J. Coté, +1 more
- 01 Dec 2006 - 
TL;DR: The safe sedation of children for procedures requires a systematic approach that includes no administration of sedating medication without the safety net of medical/dental supervision, careful presedation evaluation for underlying medical or surgical conditions that would place the child at increased risk from sedating medications.
Journal ArticleDOI

Adverse sedation events in pediatrics: analysis of medications used for sedation.

TL;DR: A systematic investigation of medications associated with adverse sedation events in pediatric patients using critical incident analysis of case reports found that patients receiving medications with long plasma half-lives may benefit from a prolonged period of postsedation observation.
Journal ArticleDOI

Adverse Sedation Events in Pediatrics: A Critical Incident Analysis of Contributing Factors

TL;DR: This study identifies several features associated with adverse sedation events and poor outcome, including pulse oximetry monitoring of patients sedated in hospitals was uniformly associated with successful outcomes whereas in the nonhospital-based venue, 4 out of 5 suffered adverse outcomes.
Journal ArticleDOI

Postoperative apnea in former preterm infants after inguinal herniorrhaphy. A combined analysis.

TL;DR: The analysis suggests that the probability of apnea in non-anemic infants free of recovery-room apnea is not less than 5%, with 95% statistical confidence until postconceptual age was 48 weeks with gestational age 35 weeks.